ILMN logo

Illumina (ILMN) EBITDA

Annual EBITDA

$600.00 M
+$1.21 B+198.68%

December 29, 2024

Summary

Performance

1-Year Change

+198.68%

3-Year Change

-49.83%

5-Year Change

-55.82%

15-Year Change

-51.46%

ILMN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.97%
ILMN annual EBITDA is higher than 92.97% of companies in Healthcare sector

High & Low

All-time High

$1.36 B
ILMN annual EBITDA is currently -55.82% below its historical high of $1.36 billion

3-Year Low

-$3.92 B

Earnings dates

Last Annual Earnings Report Date

Dec 29, 2024
ILMN previous annual earnings announcement was published on Dec 29, 2024

Next Annual Earnings Report Date

N/A
ILMN next annual earnings announcement has not yet been scheduled

OtherILMNprofitabilitymetrics:

Annual Revenue

$4.37 B
ILMN annual revenue is $4.37 billion

Annual Net Income

-$1.22 B
ILMN annual net profit is -$1.22 billion

Annual EBIT

$600.00 M
ILMN annual earnings before interest & taxes is $600.00 million

Annual EPS

-$7.69
ILMN annual earnings per share is -$7.69

Quarterly EBITDA

$193.00 M
-$633.00 M-76.63%

December 29, 2024

Summary

Performance

3-Month Change

-76.63%

1-Year Change

+582.5%

3-Year Change

+582.5%

5-Year Change

+582.5%

ILMN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.85%
ILMN quarterly EBITDA is higher than 92.85% of companies in Healthcare sector

High & Low

All-time High

$826.00 M
ILMN quarterly EBITDA is currently -76.63% below its historical high of $826.00 million

3-Year Low

-$3.56 B

Earnings dates

Last Quarterly Earnings Report Date

Dec 29, 2024
ILMN previous earnings announcement was published on Dec 29, 2024

Next Quarterly Earnings Report Date

May 2, 2025
ILMN next earnings announcement is scheduled for May 2, 2025

OtherILMNprofitabilitymetrics:

Quarterly Revenue

$1.10 B
ILMN quarterly revenue is $1.10 billion

Quarterly Net Income

$187.00 M
ILMN quarterly net profit is $187.00 million

Quarterly EBIT

$193.00 M
ILMN quarterly earnings before interest & taxes is $193.00 million

Quarterly EPS

$1.17
ILMN quarterly earnings per share is $1.17

TTM EBITDA

-$815.00 M
+$233.00 M+22.23%

December 29, 2024

Summary

Performance

3-Month Change

+22.23%

1-Year Change

-34.05%

3-Year Change

-34.05%

5-Year Change

-34.05%

ILMN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.67%
ILMN TTM EBITDA is higher than 0.67% of companies in Healthcare sector

High & Low

All-time High

$1.37 B
ILMN TTM EBITDA is currently -159.40% below its historical high of $1.37 billion

3-Year Low

-$4.10 B

Earnings dates

Last Quarterly Earnings Report Date

Dec 29, 2024
ILMN previous earnings announcement was published on Dec 29, 2024

Next Quarterly Earnings Report Date

May 2, 2025
ILMN next earnings announcement is scheduled for May 2, 2025

OtherILMNprofitabilitymetrics:

TTM Revenue

$4.37 B
ILMN TTM revenue is $4.37 billion

TTM Net Income

-$1.22 B
ILMN TTM net profit is -$1.22 billion

TTM EBIT

-$1.10 B
ILMN TTM earnings before interest & taxes is -$1.10 billion

TTM EPS

-$7.68
ILMN TTM earnings per share is -$7.68

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$600.00 M
ILMN annual EBITDA is $600.00 million

Annual Net Income

-$1.22 B
ILMN annual net profit is -$1.22 billion

Annual Interest Expense

$100.00 M
ILMN annual interest expense is $100.00 million

Annual Income Tax

$44.00 M
ILMN annual income tax is $44.00 million

Annual D&A

$354.00 M
ILMN annual depreciation & amortization is $354.00 million

ILMN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+198.7%+582.5%-34.0%
3 y3 years-49.8%+582.5%-34.0%
5 y5 years-55.8%+582.5%-34.0%

ILMN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-49.8%+115.3%-76.6%+105.4%-168.1%+80.1%
5 y5-year-55.8%+115.3%-76.6%+105.4%-159.4%+80.1%
alltimeall time-55.8%+115.3%-76.6%+105.4%-159.4%+80.1%

Illumina EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$600.00 M(-198.7%)
$193.00 M(-76.6%)
-$815.00 M(-22.2%)
Sep 2024
-
$826.00 M(-144.6%)
-$1.05 B(-58.6%)
Jun 2024
-
-$1.85 B(<-9900.0%)
-$2.53 B(+295.2%)
Mar 2024
-
$17.00 M(-142.5%)
-$640.00 M(+5.3%)
Dec 2023
-$608.00 M(-84.5%)
-$40.00 M(-93.9%)
-$608.00 M(-2.1%)
Sep 2023
-
-$655.00 M(-1823.7%)
-$621.00 M(-82.4%)
Jun 2023
-
$38.00 M(-22.4%)
-$3.53 B(-14.0%)
Mar 2023
-
$49.00 M(-192.5%)
-$4.10 B(+4.8%)
Dec 2022
-$3.92 B(-427.4%)
-$53.00 M(-98.5%)
-$3.92 B(+6.6%)
Sep 2022
-
-$3.56 B(+563.5%)
-$3.67 B(-1049.6%)
Jun 2022
-
-$537.00 M(-326.6%)
$387.00 M(-67.6%)
Mar 2022
-
$237.00 M(+26.1%)
$1.20 B(+0.1%)
Dec 2021
$1.20 B(+9.5%)
$188.00 M(-62.3%)
$1.20 B(-12.9%)
Sep 2021
-
$499.00 M(+83.5%)
$1.37 B(+19.7%)
Jun 2021
-
$272.00 M(+15.3%)
$1.15 B(+4.6%)
Mar 2021
-
$236.00 M(-35.3%)
$1.10 B(+0.3%)
Dec 2020
$1.09 B(-19.6%)
$365.00 M(+33.7%)
$1.09 B(+3.8%)
Sep 2020
-
$273.00 M(+23.0%)
$1.05 B(-5.0%)
Jun 2020
-
$222.00 M(-4.7%)
$1.11 B(-14.5%)
Mar 2020
-
$233.00 M(-28.3%)
$1.30 B(-4.6%)
Dec 2019
$1.36 B(+20.2%)
$325.00 M(-0.9%)
$1.36 B(+3.5%)
Sep 2019
-
$328.00 M(-20.0%)
$1.31 B(+2.8%)
Jun 2019
-
$410.00 M(+39.0%)
$1.28 B(+10.6%)
Mar 2019
-
$295.00 M(+5.7%)
$1.15 B(+2.1%)
Dec 2018
$1.13 B(-8.6%)
$279.00 M(-4.5%)
$1.13 B(+0.5%)
Sep 2018
-
$292.00 M(+1.4%)
$1.12 B(+6.2%)
Jun 2018
-
$288.00 M(+6.3%)
$1.06 B(+10.6%)
Mar 2018
-
$271.00 M(-0.7%)
$957.00 M(-22.5%)
Dec 2017
$1.24 B(+68.2%)
$273.00 M(+20.8%)
$1.24 B(+8.1%)
Sep 2017
-
$226.00 M(+20.9%)
$1.14 B(+2.4%)
Jun 2017
-
$187.00 M(-65.9%)
$1.11 B(-1.1%)
Mar 2017
-
$549.00 M(+205.0%)
$1.13 B(+53.3%)
Dec 2016
$735.00 M(-2.4%)
$180.00 M(-9.5%)
$735.00 M(+0.5%)
Sep 2016
-
$199.00 M(0.0%)
$731.02 M(+3.5%)
Jun 2016
-
$199.00 M(+26.8%)
$706.61 M(+2.3%)
Mar 2016
-
$157.00 M(-10.8%)
$690.69 M(-8.3%)
Dec 2015
$753.00 M(+24.9%)
$176.02 M(+0.8%)
$753.00 M(-7.0%)
Sep 2015
-
$174.59 M(-4.6%)
$810.07 M(+3.1%)
Jun 2015
-
$183.08 M(-16.5%)
$785.60 M(+12.2%)
Mar 2015
-
$219.31 M(-5.9%)
$700.43 M(+16.1%)
Dec 2014
$603.06 M(+103.1%)
$233.09 M(+55.3%)
$603.06 M(+14.3%)
Sep 2014
-
$150.12 M(+53.3%)
$527.45 M(+16.9%)
Jun 2014
-
$97.91 M(-19.7%)
$451.31 M(+3.5%)
Mar 2014
-
$121.94 M(-22.6%)
$436.15 M(+46.9%)
Dec 2013
$296.93 M(-8.8%)
$157.48 M(+112.9%)
$296.93 M(+9.3%)
Sep 2013
-
$73.98 M(-10.6%)
$271.56 M(+1.7%)
Jun 2013
-
$82.75 M(-578.8%)
$267.00 M(+9.6%)
Mar 2013
-
-$17.28 M(-113.1%)
$243.52 M(-25.2%)
Dec 2012
$325.71 M
$132.11 M(+90.3%)
$325.71 M(+34.4%)
Sep 2012
-
$69.42 M(+17.1%)
$242.39 M(+6.8%)
DateAnnualQuarterlyTTM
Jun 2012
-
$59.28 M(-8.7%)
$227.07 M(-6.4%)
Mar 2012
-
$64.90 M(+33.0%)
$242.72 M(+2.4%)
Dec 2011
$237.03 M(-5.9%)
$48.80 M(-9.8%)
$237.03 M(-7.9%)
Sep 2011
-
$54.09 M(-27.8%)
$257.22 M(-6.5%)
Jun 2011
-
$74.93 M(+26.5%)
$275.13 M(+4.7%)
Mar 2011
-
$59.21 M(-14.2%)
$262.87 M(+4.3%)
Dec 2010
$251.99 M(+49.1%)
$68.99 M(-4.2%)
$251.99 M(+14.8%)
Sep 2010
-
$72.00 M(+14.9%)
$219.56 M(+16.0%)
Jun 2010
-
$62.67 M(+29.7%)
$189.20 M(+8.1%)
Mar 2010
-
$48.33 M(+32.2%)
$175.04 M(+3.6%)
Dec 2009
$169.03 M(+37.8%)
$36.56 M(-12.2%)
$169.03 M(+1.8%)
Sep 2009
-
$41.64 M(-14.2%)
$166.06 M(+5.6%)
Jun 2009
-
$48.51 M(+14.7%)
$157.19 M(+12.7%)
Mar 2009
-
$42.31 M(+26.0%)
$139.47 M(+13.7%)
Dec 2008
$122.62 M(+580.7%)
$33.59 M(+2.5%)
$122.62 M(+97.4%)
Sep 2008
-
$32.78 M(+6.5%)
$62.11 M(+31.8%)
Jun 2008
-
$30.79 M(+20.9%)
$47.11 M(+44.9%)
Mar 2008
-
$25.46 M(-194.6%)
$32.51 M(+80.5%)
Dec 2007
$18.01 M(-58.6%)
-$26.92 M(-251.4%)
$18.02 M(-71.5%)
Sep 2007
-
$17.79 M(+9.9%)
$63.29 M(+1.6%)
Jun 2007
-
$16.19 M(+47.6%)
$62.32 M(+15.4%)
Mar 2007
-
$10.97 M(-40.2%)
$54.02 M(+24.1%)
Dec 2006
$43.52 M(-2737.6%)
$18.35 M(+9.1%)
$43.52 M(+62.1%)
Sep 2006
-
$16.82 M(+113.2%)
$26.85 M(+186.8%)
Jun 2006
-
$7.89 M(+1596.6%)
$9.36 M(-1753.9%)
Mar 2006
-
$465.00 K(-72.3%)
-$566.00 K(-65.7%)
Dec 2005
-$1.65 M(+220.4%)
$1.68 M(-349.9%)
-$1.65 M(-430.0%)
Sep 2005
-
-$672.00 K(-67.0%)
$500.00 K(+5.0%)
Jun 2005
-
-$2.04 M(+229.2%)
$476.00 K(-22.5%)
Mar 2005
-
-$619.00 K(-116.2%)
$614.00 K(-219.2%)
Dec 2004
-$515.00 K(-97.3%)
$3.83 M(-650.1%)
-$515.00 K(-92.1%)
Sep 2004
-
-$696.00 K(-63.4%)
-$6.52 M(-30.8%)
Jun 2004
-
-$1.90 M(+8.7%)
-$9.42 M(-32.9%)
Mar 2004
-
-$1.75 M(-19.6%)
-$14.04 M(-26.9%)
Dec 2003
-$19.19 M(-40.7%)
-$2.17 M(-39.6%)
-$19.19 M(-80.2%)
Sep 2003
-
-$3.60 M(-44.7%)
-$97.06 M(+21.9%)
Jun 2003
-
-$6.51 M(-5.7%)
-$79.63 M(-9.1%)
Mar 2003
-
-$6.90 M(-91.4%)
-$87.56 M(+0.4%)
Dec 2002
-$32.35 M(+43.4%)
-$80.04 M(-678.8%)
-$87.25 M(+519.5%)
Sep 2002
-
$13.83 M(-195.7%)
-$14.08 M(-57.6%)
Jun 2002
-
-$14.44 M(+119.1%)
-$33.23 M(+37.0%)
Mar 2002
-
-$6.59 M(-4.1%)
-$24.26 M(+7.5%)
Dec 2001
-$22.56 M(+40.6%)
-$6.88 M(+29.2%)
-$22.56 M(+11.0%)
Sep 2001
-
-$5.32 M(-2.7%)
-$20.31 M(+10.4%)
Jun 2001
-
-$5.47 M(+11.7%)
-$18.39 M(+9.7%)
Mar 2001
-
-$4.89 M(+5.6%)
-$16.77 M(+4.5%)
Dec 2000
-$16.04 M(+229.8%)
-$4.63 M(+36.1%)
-$16.04 M(+40.6%)
Sep 2000
-
-$3.40 M(-11.4%)
-$11.41 M(+42.5%)
Jun 2000
-
-$3.84 M(-7.7%)
-$8.00 M(+92.3%)
Mar 2000
-
-$4.16 M
-$4.16 M
Dec 1999
-$4.86 M
-
-

FAQ

  • What is Illumina annual EBITDA?
  • What is the all time high annual EBITDA for Illumina?
  • What is Illumina annual EBITDA year-on-year change?
  • What is Illumina quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Illumina?
  • What is Illumina quarterly EBITDA year-on-year change?
  • What is Illumina TTM EBITDA?
  • What is the all time high TTM EBITDA for Illumina?
  • What is Illumina TTM EBITDA year-on-year change?

What is Illumina annual EBITDA?

The current annual EBITDA of ILMN is $600.00 M

What is the all time high annual EBITDA for Illumina?

Illumina all-time high annual EBITDA is $1.36 B

What is Illumina annual EBITDA year-on-year change?

Over the past year, ILMN annual EBITDA has changed by +$1.21 B (+198.68%)

What is Illumina quarterly EBITDA?

The current quarterly EBITDA of ILMN is $193.00 M

What is the all time high quarterly EBITDA for Illumina?

Illumina all-time high quarterly EBITDA is $826.00 M

What is Illumina quarterly EBITDA year-on-year change?

Over the past year, ILMN quarterly EBITDA has changed by +$233.00 M (+582.50%)

What is Illumina TTM EBITDA?

The current TTM EBITDA of ILMN is -$815.00 M

What is the all time high TTM EBITDA for Illumina?

Illumina all-time high TTM EBITDA is $1.37 B

What is Illumina TTM EBITDA year-on-year change?

Over the past year, ILMN TTM EBITDA has changed by -$207.00 M (-34.05%)